Complementary Biophysical Approaches to Assess Fragment Binding

Abstract

Fragment-based approaches have been applied successfully to the discovery and optimization of ligands for a wide range of targets.

Fragment-based lead discovery (FBLD) is proving particularly valuable for bromodomain (BRD)-containing proteins which are potential therapeutic targets for cancer, inflammation and multiple sclerosis.